AQILION AB

📍 Helsingborg, Sweden👥 17 employees💰 Last funded Jun 2021
Biotechnology Research🌐 aqilion.com
Website LinkedIn
Aqilion is a Swedish life science company. We believe the best source of new treatments comes from identifying, shaping and strengthening early drug innovation. We seek ideas that could potentially both improve patient quality of life and streamline health care. Aqilion harbors the backbone core management, financing resources and business administration together with a network of skilled competences and seek to match that with external sources of innovation from academia or industry. Aqilion pursues and transforms ideas aimed at testing and refining science into clinical translation. The goal is to deliver clinical proof-of-concept and an interesting value proposition to attract industrial partners fitted to drive the late phases of clinical development and commercialization.
3
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Sweden
3
Investor activity2014–2021 · investors recorded per year
201412019120211
Recent (last 2y)Earlier
Frequently asked questions
Who invested in AQILION AB?
AQILION AB has 3 investors on record on gritt.io.
When did AQILION AB last raise funding?
The most recent investment in AQILION AB recorded on gritt.io was in June 2021.
What industry is AQILION AB in?
AQILION AB operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is AQILION AB based?
AQILION AB is headquartered in Helsingborg, Sweden.